Filing Details
- Accession Number:
- 0001935979-24-000077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-03 07:00:38
- Reporting Period:
- 2024-10-02
- Accepted Time:
- 2024-10-03 07:00:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1935979 | Biohaven Ltd. | BHVN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1704317 | Vlad Coric | C/O Biohaven Ltd. 215 Church Street New Haven CT 06510 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2024-10-02 | 21,052 | $47.50 | 861,942 | No | 4 | P | Indirect | By: The Vlad Coric Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By: The Vlad Coric Family Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares | 407,213 | Indirect | By: The Vladimir Coric Marital Trust |
Common Shares | 109,565 | Indirect | By: 401(K) Plan |
Common Shares | 1,789,159 | Direct |
Footnotes
- Represents common shares acquired in an underwritten public offering.
- These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- This balance includes 742 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2024.